But Cowen and Co. analyst Steve Scala wrote that Cordaptive 's safety profile " trended less favorably " than extended-release niacin , with measures of substances in the blood that can indicate potential liver damage , muscle damage and blood-sugar problems a little worse for Cordaptive than the extended-release niacin .